Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CD8: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CD8 is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, inhibits. Associated with ALS, Aging, Als. Connected to 614 entities in the SciDEX knowledge graph.
| Gene Symbol | CD8A, CD8B |
| Aliases | CD8 |
| Chromosome | 2p11.2 (CD8A), 2p11.2 (CD8B) |
| Protein Family | Immunoglobulin superfamily |
| Protein Type | Receptor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | ~25-32 kDa (heterodimer) |
| Pathways | Adaptive Immunity, Amyloid, Apoptosis, Autophagy, Cholesterol |
| UniProt ID | P01732 (CD8A), P10966 (CD8B) |
| NCBI Gene ID | 931 (CD8A), 915 (CD8B) |
| Gene Name | CD8 Alpha Chain, CD8 Beta Chain |
| Ig-like V-type domain | MHC class I binding |
| Hinge region | Flexibility for optimal interaction |
| Target | Approach |
| CD8+ T cell depletion | Anti-CD8 antibodies |
| Associated Diseases | ALS, Aging, Alzheimer, Amyotrophic Lateral Sclerosis, Arthritis |
| Known Drugs/Compounds | dimethyl fumarate |
| Interactions | PDGFRB, ANGPT1, IRF1, CIITA, RIPK1, RIPK3 |
| KG Connections | 1156 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
CD8(["CD8"])
Cancer["Cancer"]
Tumor["Tumor"]
Als["Als"]
Inflammation["Inflammation"]
GENES(["GENES"])
CANCER(["CANCER"])
INFLAMMATION(["INFLAMMATION"])
Lung_Cancer["Lung Cancer"]
STING(["STING"])
Checkpoint_Inhibitor["Checkpoint Inhibitor"]
Immunotherapy["Immunotherapy"]
CD8 -->|"activates"| Cancer
CD8 -->|"activates"| Tumor
CD8 -->|"therapeutic target"| Cancer
CD8 -->|"activates"| Als
CD8 -.->|"inhibits"| Cancer
CD8 -->|"activates"| Inflammation
GENES -->|"activates"| CD8
CANCER -->|"activates"| CD8
CANCER -->|"therapeutic target"| CD8
INFLAMMATION -->|"activates"| CD8
CD8 -.->|"inhibits"| Tumor
CD8 -->|"activates"| Lung_Cancer
CD8 -->|"activates"| STING
CD8 -->|"activates"| Checkpoint_Inhibitor
CD8 -->|"therapeutic target"| Immunotherapy
style CD8 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | activates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Tumor | inhibits | disease | 0.95 |
| Lung Cancer | activates | disease | 0.95 |
| T CELLS | interacts_with | cell_type | 0.95 |
| T cells | associated_with | cell_type | 0.90 |
| STING | activates | gene | 0.90 |
| Checkpoint Inhibitor | activates | pathway | 0.90 |
| Immunotherapy | therapeutic_target | pathway | 0.90 |
| Tumor Microenvironment | activates | pathway | 0.90 |
| Immune Checkpoint | activates | pathway | 0.90 |
| Als | expressed_in | disease | 0.85 |
| Carcinoma | activates | disease | 0.85 |
| Als | inhibits | disease | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| Tumor | associated_with | disease | 0.85 |
| Tumor | regulates | disease | 0.85 |
| Cancer | regulates | disease | 0.85 |
| Carcinoma | therapeutic_target | disease | 0.85 |
| Tumor | therapeutic_target | disease | 0.85 |
| T CELLS | activates | cell_type | 0.80 |
| T cells | activates | cell_type | 0.80 |
| T cells | expressed_in | cell_type | 0.80 |
| Glioblastoma | biomarker_for | disease | 0.80 |
| T cells | modulates | cell_type | 0.80 |
| oxidative stress response | participates_in | pathway | 0.80 |
| CD4 | associated_with | gene | 0.80 |
| MYC | activates | gene | 0.80 |
| Phagocytosis | activates | pathway | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Autophagy | activates | pathway | 0.80 |
| Immune Response | inhibits | pathway | 0.80 |
| MICROGLIA | activates | gene | 0.80 |
| IFN | activates | gene | 0.80 |
| Immunotherapy | activates | pathway | 0.80 |
| Cancer | expressed_in | disease | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| Aging | activates | disease | 0.75 |
| Parkinson | expressed_in | disease | 0.75 |
| Inflammation | expressed_in | disease | 0.75 |
| Inflammation | associated_with | disease | 0.75 |
| Aging | inhibits | disease | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Carcinoma | expressed_in | disease | 0.75 |
| Carcinoma | inhibits | disease | 0.75 |
| Als | regulates | disease | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GENES | activates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| APOPTOSIS | activates | gene | 0.90 |
| CD19 | associated_with | gene | 0.80 |
| CCL5 | activates | gene | 0.80 |
| STING | activates | gene | 0.80 |
| GENES | associated_with | gene | 0.80 |
| CANCER | inhibits | gene | 0.80 |
| GSDME | activates | gene | 0.70 |
| CXCL10 | activates | gene | 0.70 |
| CD4 | inhibits | gene | 0.70 |
| TREX1 | activates | gene | 0.70 |
| STAT3 | activates | gene | 0.70 |
| CD4 | therapeutic_target | gene | 0.70 |
| EGFR | activates | gene | 0.70 |
| CD40 | activates | gene | 0.70 |
| AGING | inhibits | gene | 0.70 |
| CANCER | regulates | gene | 0.70 |
| CANCER | expressed_in | gene | 0.70 |
| PHAGOCYTOSIS | activates | gene | 0.70 |
| APOPTOSIS | inhibits | gene | 0.70 |
| PARKINSON | expressed_in | gene | 0.70 |
| INFLAMMATION | expressed_in | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| PARKINSON'S DISEASE | expressed_in | gene | 0.70 |
| MHC-I | inhibits | gene | 0.70 |
| beta_hydroxybutyrate | regulates | drug | 0.64 |
| glycogen_metabolism | regulates | pathway | 0.64 |
| NPM1 | activates | gene | 0.60 |
| NLRC5 | activates | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| MAF | inhibits | gene | 0.60 |
| SPP1 | associated_with | gene | 0.60 |
| STING | associated_with | gene | 0.60 |
| PDGFRB | activates | gene | 0.60 |
| IRF1 | activates | gene | 0.60 |
| CIITA | activates | gene | 0.60 |
| CD4 | associated_with | gene | 0.60 |
| STAR | expressed_in | gene | 0.60 |
| RIPK3 | activates | gene | 0.60 |
| RIPK1 | activates | gene | 0.60 |
| PRDM1 | inhibits | gene | 0.60 |
| CAMK4 | associated_with | gene | 0.60 |
| CD4 | expressed_in | gene | 0.60 |
| GPX4 | inhibits | gene | 0.60 |
| LDLR | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neuroimmunology | 2026-04-15 | 1 hypotheses Top: 0.514
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||